High quality, price stability commitment to customers
High quality, price stability commitment to customers
PT Meiji Indonesia is a pioneer of quality antibiotic products for both domestic and international markets. This is the unique and clear image of PT Meiji Indonesia, a company highly specialized in pharmaceuticals.
For the past 24 years, it has produced over 215 million vials, 500 million capsules and 500 million tablets, under such medicine trade marks as Troches, Viccillin, Dibekacin, Kanamycin and Meixam; all have been used by producers throughout Indonesia, the ASEAN region and Japan.
All products are guaranteed high quality, with integrated supervision supported by Meiji Seika Kaisha Ltd Japan standards and certified by the Indonesian government to local medical production standards. Products consist of 99 percent prescription drugs and 1 percent over-the-counter medicines for the domestic market.
The company and its employees share a perception concerning the relationship between production quality and employees welfare: "Employee enhancement brings company enhancement, and company enhancement translates into improved employee benefits." PT Meiji Indonesia has won 16 awards at regional as well as national levels, including one for environmental consciousness and a subregional first prize for the implementation of norm K3 Chemical industry sector.
PT Meiji Indonesia's President Director, T. Nakazono, pays major attention to pricing. He is committed to keeping prices affordable for the public despite the fact that real market prices have increased from April by 45 percent to 75 percent. It is untrue, he said, that because of the economic crisis medicine prices have increased 200 percent. If this has happened, he said, it is because of a distribution factor or too many speculators.
Nakazono suggested making a pharmaceutical association which could control price stability. And the government should carry out tight supervision in order to eliminate speculators and to stabilize the distribution process and prices of raw materials.